Celldex Therapeutics Inc Long-term Investment Intensity
Celldex Therapeutics Inc long-term investment intensity. Celldex Therapeutics Inc (CLDX) has a Long-term Investment Intensity of 1.2% as of December 2018. Long-term investments of $1.80 Million represent 1.2% of total assets of $155.81 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See Celldex Therapeutics Inc (CLDX) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of Celldex Therapeutics Inc (2017–2018)
Long-term investment intensity of Celldex Therapeutics Inc from 2017 to 2018. This chart shows how Celldex Therapeutics Inc's Long-term Investment Intensity has evolved across 2 annual periods from 2017 to 2018. As of December 2018, the intensity stands at 1.2%, reflecting long-term investments of $1.80 Million against total assets of $155.81 Million USD. See operational self-sufficiency of Celldex Therapeutics Inc to measure how many days the company can operate on defensive assets alone.
Celldex Therapeutics Inc Long-term Investment Intensity by Year (2017–2018)
Celldex Therapeutics Inc long-term investment intensity by year from 2017 to 2018. The table below presents the year-by-year Long-term Investment Intensity for Celldex Therapeutics Inc from 2017 to 2018, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see total assets of Celldex Therapeutics Inc.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 1.2% | $1.80 Million | $155.81 Million | ▲ +0.6 pp |
| 2017 | 0.6% | $1.80 Million | $315.62 Million | — |